Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component
申请人:Lee Jung Joon
公开号:US08394799B2
公开(公告)日:2013-03-12
Disclosed herein are an HIF-1 inhibitor, a method for the preparation thereof, and a pharmaceutical composition comprising the same as an active ingredient. The HIF-1 inhibitor shows anticancer activity thanks to the inhibition activity against HIF-1, a transcription factor which plays an important role in the growth and metastasis of cancer, but not to general cytotoxicity. Thus, the HIF-inhibitor and a pharmaceutically acceptable salt thereof can be used as a therapeutic for various cancers such as liver cancer; stomach cancer and breast cancer. Also, the compound having inhibition activity against HIF-1 is useful in the treatment of diabetic retinopathy and arthritis, which are aggravated by HIF-1-mediated VEGF expression.
本发明涉及一种HIF-1抑制剂,其制备方法以及包含该抑制剂作为活性成分的制药组合物。该HIF-1抑制剂通过对HIF-1的抑制活性表现出抗癌活性,HIF-1是一种转录因子,在癌症的生长和转移中起着重要作用,但不具有普遍的细胞毒性。因此,HIF抑制剂及其药学上可接受的盐可以用作各种癌症(如肝癌、胃癌和乳腺癌)的治疗剂。此外,具有对HIF-1抑制活性的化合物对于治疗由HIF-1介导的VEGF表达加重的糖尿病视网膜病变和关节炎非常有用。